Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no user-visible changes to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now lists updated study locations, adding Connecticut, Louisiana, Minnesota, Missouri, South Carolina, Tennessee, British Columbia, and Manitoba, and includes a revision note (v3.3.3). The previous location sections have been removed, reflecting an update to the location information presented on the page.
    Difference
    0.9%
    Check dated 2025-12-23T09:22:37.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The Publications section now states that items are automatically filled from PubMed, and the revision stamp was updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:56:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the generic government funding/operating status banner from the page. This change does not affect the study details, eligibility criteria, or results.
    Difference
    0.3%
    Check dated 2025-11-17T18:04:03.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    No significant additions or deletions were observed between the two versions of the page; the study details content and layout appear unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T12:37:39.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T16:44:45.000Z thumbnail image

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.